Mutual	O
regulation	O
of	O
the	O
transcriptional	B-protein
activator	I-protein
NF-kappa	B-protein
B	I-protein
and	O
its	O
inhibitor	O
,	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
.	O

The	O
NK-kappa	B-protein
B	I-protein
transcription	I-protein
factor	I-protein
complex	I-protein
is	O
sequestered	O
in	O
the	O
cytoplasm	O
by	O
the	O
inhibitory	O
protein	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
(	O
MAD-3	B-protein
)	O
.	O

Various	O
cellular	O
stimuli	O
relieve	O
this	O
inhibition	O
by	O
mechanisms	O
largely	O
unknown	O
,	O
leading	O
to	O
NF-kappa	B-protein
B	I-protein
nuclear	O
localization	O
and	O
transactivation	O
of	O
its	O
target	O
genes	O
.	O

It	O
is	O
demonstrated	O
here	O
with	O
human	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
and	O
monocytes	B-cell_type
that	O
different	O
stimuli	O
,	O
including	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
and	O
phorbol	O
12-myristate	O
13-acetate	O
,	O
cause	O
rapid	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
,	O
with	O
concomitant	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
followed	O
by	O
a	O
dramatic	O
increase	O
in	O
I	B-RNA
kappa	I-RNA
B-alpha	I-RNA
mRNA	I-RNA
and	O
protein	O
synthesis	O
.	O

Transfection	O
studies	O
reveal	O
that	O
the	O
I	B-RNA
kappa	I-RNA
B-alpha	I-RNA
mRNA	I-RNA
and	O
the	O
encoded	O
protein	O
are	O
potently	O
induced	O
by	O
NF-kappa	B-protein
B	I-protein
and	O
by	O
homodimers	O
of	O
p65	B-protein
and	O
of	O
c-Rel	B-protein
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
NF-kappa	B-protein
B	I-protein
and	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
mutually	O
regulate	O
each	O
other	O
in	O
a	O
cycle	O
:	O
saturating	O
amounts	O
of	O
the	O
inhibitory	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
protein	O
are	O
destroyed	O
upon	O
stimulation	O
,	O
allowing	O
rapid	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
.	O

Subsequently	O
,	O
I	B-RNA
kappa	I-RNA
B-alpha	I-RNA
mRNA	I-RNA
and	O
protein	O
levels	O
are	O
quickly	O
induced	O
by	O
the	O
activated	O
NF-kappa	B-protein
B	I-protein
.	O

This	O
resurgence	O
of	O
I	B-protein
kappa	I-protein
B-alpha	I-protein
protein	O
acts	O
to	O
restore	O
an	O
equilibrium	O
in	O
which	O
NF-kappa	B-protein
B	I-protein
is	O
again	O
inhibited	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

90	NULL
,	NULL
pp	NULL
.	NULL

2532-2536	NULL
,	NULL
March	NULL
1993	NULL
Immunology	NULL
Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
Ix	NULL
B-a	NULL
(	NULL
gene	NULL
regulation/cell	NULL
activation	NULL
/human	NULL
immunodeficiency	NULL
virus	NULL
/transcription	NULL
factor	NULL
/nuclear	NULL
translocation	NULL
)	NULL
KEITH	NULL
Brown	NULL
,	NULL
SUN	NULL
PARK	NULL
,	NULL
TOMOHIKO	NULL
KANNO	NULL
,	NULL
GUIDO	NULL
FRANZOSO*	NULL
,	NULL
AND	NULL
ULRICH	NULL
SIEBENLIST	NULL
Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
Communicated	NULL
by	NULL
Anthony	NULL
S.	NULL
Fauci	NULL
,	NULL
December	NULL
29	NULL
,	NULL
1992	NULL
(	NULL
received	NULL
for	NULL
review	NULL
December	NULL
11	NULL
,	NULL
1992	NULL
)	NULL
ABSTRACT	NULL
The	NULL
NF-B	NULL
transcription	NULL
factor	NULL
complex	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
the	NULL
inhibitory	NULL
protein	NULL
IxB-a	NULL
(	NULL
MAD-3	NULL
)	NULL
.	NULL

Various	NULL
cellular	NULL
stimuli	NULL
relieve	NULL
this	NULL
inhibition	NULL
by	NULL
mechanisms	NULL
largely	NULL
unknown	NULL
,	NULL
leading	NULL
to	NULL
NF-xB	NULL
nuclear	NULL
localization	NULL
and	NULL
transactivation	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
.	NULL

It	NULL
is	NULL
demonstrated	NULL
here	NULL
with	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
that	NULL
different	NULL
stimuli	NULL
,	NULL
including	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
,	NULL
cause	NULL
rapid	NULL
degradation	NULL
of	NULL
IxB-a	NULL
,	NULL
with	NULL
concomitant	NULL
activation	NULL
of	NULL
NF-	NULL
B	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
IxB-a	NULL
mRNA	NULL
and	NULL
protein	NULL
synthesis	NULL
.	NULL

Transfection	NULL
studies	NULL
reveal	NULL
that	NULL
the	NULL
IxB-a	NULL
mRNA	NULL
and	NULL
the	NULL
encoded	NULL
protein	NULL
are	NULL
potently	NULL
induced	NULL
by	NULL
NF-xB	NULL
and	NULL
by	NULL
homodimers	NULL
of	NULL
p65	NULL
and	NULL
of	NULL
c-Rel	NULL
.	NULL

We	NULL
propose	NULL
a	NULL
model	NULL
in	NULL
which	NULL
NF-xB	NULL
and	NULL
IxB-a	NULL
mutually	NULL
regulate	NULL
each	NULL
other	NULL
in	NULL
a	NULL
cycle	NULL
:	NULL
saturating	NULL
amounts	NULL
of	NULL
the	NULL
inhibitory	NULL
IxB-a	NULL
protein	NULL
are	NULL
destroyed	NULL
upon	NULL
stimulation	NULL
,	NULL
allowing	NULL
rapid	NULL
activation	NULL
of	NULL
NF-B	NULL
.	NULL

Subsequently	NULL
,	NULL
IxB-a	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
are	NULL
quickly	NULL
induced	NULL
by	NULL
the	NULL
activated	NULL
NF-xB	NULL
.	NULL

This	NULL
resurgence	NULL
of	NULL
IxB-a	NULL
protein	NULL
acts	NULL
to	NULL
restore	NULL
an	NULL
equilibrium	NULL
in	NULL
which	NULL
is	NULL
again	NULL
inhibited	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
dimeric	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
and	NULL
regulates	NULL
gene	NULL
expression	NULL
through	NULL
decameric	NULL
cis-acting	NULL
«	NULL
B	NULL
DNA	NULL
motifs	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
p50/p65	NULL
heterodimer	NULL
has	NULL
traditionally	NULL
been	NULL
referred	NULL
to	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
remains	NULL
the	NULL
prototypical	NULL
and	NULL
most	NULL
abundant	NULL
form	NULL
,	NULL
it	NULL
has	NULL
been	NULL
recognized	NULL
recently	NULL
that	NULL
several	NULL
distinct	NULL
but	NULL
closely	NULL
related	NULL
homo-	NULL
and	NULL
heterodimeric	NULL
factors	NULL
are	NULL
responsible	NULL
for	NULL
«	NULL
B	NULL
site-dependent	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
regulation	NULL
.	NULL

The	NULL
various	NULL
dimeric	NULL
factors	NULL
are	NULL
composed	NULL
of	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
Rel-related	NULL
polypeptides	NULL
.	NULL

One	NULL
subclass	NULL
of	NULL
this	NULL
family	NULL
,	NULL
distinguished	NULL
by	NULL
its	NULL
proteolytic	NULL
processing	NULL
from	NULL
precursor	NULL
forms	NULL
and	NULL
lack	NULL
of	NULL
recognized	NULL
activation	NULL
domains	NULL
,	NULL
includes	NULL
p50	NULL
(	NULL
NFKB1	NULL
)	NULL
(	NULL
3-6	NULL
)	NULL
and	NULL
p50B	NULL
(	NULL
NFKB2	NULL
,	NULL
p52	NULL
)	NULL
(	NULL
7-10	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
second	NULL
subclass	NULL
contains	NULL
recognized	NULL
activation	NULL
domains	NULL
and	NULL
includes	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
(	NULL
11-13	NULL
)	NULL
,	NULL
RelB	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
16	NULL
)	NULL
,	NULL
v-Rel	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Drosophila	NULL
protein	NULL
Dorsal	NULL
(	NULL
19	NULL
)	NULL
.	NULL

All	NULL
Rel-related	NULL
members	NULL
share	NULL
a	NULL
300-amino	NULL
acid	NULL
region	NULL
of	NULL
homology	NULL
,	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
,	NULL
called	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
various	NULL
related	NULL
forms	NULL
can	NULL
be	NULL
initiated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
agents	NULL
,	NULL
including	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Activation	NULL
proceeds	NULL
through	NULL
a	NULL
post-translational	NULL
event	NULL
in	NULL
which	NULL
preformed	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
released	NULL
from	NULL
a	NULL
cytoplasmic	NULL
inhibitory	NULL
protein	NULL
,	NULL
IxB-a	NULL
(	NULL
MAD-3	NULL
)	NULL
(	NULL
20-23	NULL
)	NULL
.	NULL

IxB-a	NULL
inhibits	NULL
transactivation	NULL
of	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
,	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
p65	NULL
component	NULL
,	NULL
blocking	NULL
the	NULL
dimer	NULL
's	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
20	NULL
,	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

IxB-a	NULL
also	NULL
inhibits	NULL
complexes	NULL
containing	NULL
c-Rel	NULL
or	NULL
RelB	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

IxB-a	NULL
blocks	NULL
binding	NULL
in	NULL
vitro	NULL
of	NULL
various	NULL
NF-KB	NULL
dimers	NULL
to	NULL
xB	NULL
binding	NULL
sites	NULL
in	NULL
DNA	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
22	NULL
,	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

2532	NULL
latter	NULL
effect	NULL
requires	NULL
nuclear	NULL
IxB-a	NULL
,	NULL
its	NULL
relevance	NULL
,	NULL
in	NULL
vivo	NULL
,	NULL
is	NULL
unknown	NULL
.	NULL

Although	NULL
IxB-a	NULL
is	NULL
generally	NULL
a	NULL
cytoplasmic	NULL
protein	NULL
(	NULL
21	NULL
,	NULL
23	NULL
)	NULL
,	NULL
it	NULL
and	NULL
its	NULL
chicken	NULL
homolog	NULL
(	NULL
pp40	NULL
)	NULL
have	NULL
also	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
refs	NULL
.	NULL

28-30	NULL
and	NULL
K.B	NULL
.	NULL

,	NULL
G.F.	NULL
,	NULL
and	NULL
U.S.	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
well-characterized	NULL
and	NULL
cloned	NULL
IxB-a	NULL
and	NULL
its	NULL
chicken	NULL
and	NULL
rat	NULL
homologs	NULL
(	NULL
24	NULL
,	NULL
31	NULL
)	NULL
,	NULL
another	NULL
biochemically	NULL
defined	NULL
form	NULL
,	NULL
IkB-B	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
,	NULL
but	NULL
this	NULL
remains	NULL
to	NULL
be	NULL
fully	NULL
characterized	NULL
(	NULL
26	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IxB-a	NULL
in	NULL
vitro	NULL
by	NULL
protein	NULL
kinases	NULL
A	NULL
and	NULL
C	NULL
and	NULL
heme-activated	NULL
kinase	NULL
abolished	NULL
IxB-a	NULL
's	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
24	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Although	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
conjectured	NULL
to	NULL
proceed	NULL
through	NULL
phosphorylation	NULL
,	NULL
no	NULL
modification	NULL
of	NULL
IxB-a	NULL
has	NULL
yet	NULL
been	NULL
reported	NULL
in	NULL
vivo	NULL
.	NULL

It	NULL
is	NULL
also	NULL
unknown	NULL
how	NULL
the	NULL
inhibited	NULL
state	NULL
is	NULL
maintained	NULL
in	NULL
unstimulated	NULL
cells-that	NULL
is	NULL
,	NULL
how	NULL
the	NULL
ratio	NULL
of	NULL
IxB-a	NULL
protein	NULL
to	NULL
target	NULL
complexes	NULL
is	NULL
regulated	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
a	NULL
mutual	NULL
cycle	NULL
of	NULL
regulation	NULL
of	NULL
IxB-a	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
exists	NULL
.	NULL

Stimulation	NULL
results	NULL
in	NULL
a	NULL
rapid	NULL
loss	NULL
of	NULL
IxB-a	NULL
from	NULL
cells	NULL
(	NULL
probably	NULL
following	NULL
its	NULL
modification	NULL
)	NULL
and	NULL
the	NULL
rapid	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Transactivation	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
induces	NULL
high	NULL
levels	NULL
of	NULL
IkB-a	NULL
synthesis	NULL
,	NULL
which	NULL
can	NULL
then	NULL
restore	NULL
the	NULL
unstimulated	NULL
inhibited	NULL
state	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Extract	NULL
Preparations	NULL
and	NULL
Transfections	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
centrifugation	NULL
after	NULL
freeze-thawing	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
in	NULL
NTera-2	NULL
cells	NULL
using	NULL
the	NULL
PMT2T	NULL
vector	NULL
plasmid	NULL
as	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
PMT2T-I	NULL
«	NULL
B-	NULL
«	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
an	NULL
EcoRI	NULL
fragment	NULL
of	NULL
1550	NULL
nucleotide	NULL
pairs	NULL
containing	NULL
full-length	NULL
IxB-	NULL
«	NULL
/MAD-3	NULL
cDNA	NULL
(	NULL
22	NULL
)	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
PMT2T	NULL
.	NULL

PMT2T-p65	NULL
and	NULL
p50	NULL
plasmids	NULL
were	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

PMT2T	NULL
c-Rel	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
the	NULL
EcoRI	NULL
fragment	NULL
of	NULL
full-length	NULL
human	NULL
c-Rel	NULL
cDNA	NULL
(	NULL
16	NULL
)	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
PMT2T	NULL
.	NULL

Western	NULL
Blotting	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
SDS/	NULL
PAGE	NULL
and	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
BA8S	NULL
)	NULL
,	NULL
and	NULL
IxB-a	NULL
was	NULL
detected	NULL
with	NULL
polyclonal	NULL
rabbit	NULL
antibody	NULL
directed	NULL
against	NULL
either	NULL
N-	NULL
or	NULL
C-terminal	NULL
domains	NULL
(	NULL
amino	NULL
acids	NULL
1-129	NULL
and	NULL
230-315	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
both	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
second	NULL
incubation	NULL
with	NULL
'*I-labeled	NULL
protein	NULL
A	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
.	NULL

Both	NULL
antibodies	NULL
detected	NULL
the	NULL
same	NULL
protein	NULL
in	NULL
Western	NULL
blots	NULL
.	NULL

[	NULL
In	NULL
addition	NULL
,	NULL
a	NULL
peptide	NULL
antibody	NULL
directed	NULL
against	NULL
an	NULL
N-terminal	NULL
peptide	NULL
reacted	NULL
with	NULL
the	NULL
same	NULL
protein	NULL
and	NULL
this	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
competition	NULL
with	NULL
added	NULL
peptide	NULL
(	NULL
K.B	NULL
.	NULL

and	NULL
U.S.	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL
]	NULL

Northern	NULL
Blotting	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
(	NULL
35	NULL
)	NULL
,	NULL
fraction-ated	NULL
on	NULL
an	NULL
agarose	NULL
formaldehyde	NULL
gel	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
hybridized	NULL
Abbreviations	NULL
:	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
EMSA	NULL
,	NULL
electro-	NULL
phoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PD	NULL
,	NULL
palindromic	NULL
.	NULL

*On	NULL
leave	NULL
from	NULL
:	NULL
Servizio	NULL
di	NULL
Microbiologica	NULL
del	NULL
Complesso	NULL
Conven-zionato	NULL
Universita-U.L.S.S	NULL
.	NULL

21	NULL
,	NULL
Via	NULL
Ospedale	NULL
2	NULL
,	NULL
35100-Padua	NULL
,	NULL
Italy	NULL
.	NULL

Immunology	NULL
:	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

A	NULL
IONOMYCIN	NULL
TNF	NULL
PMA	NULL
+	NULL
IONOMYC	NULL
+	NULL
CHX	NULL
0	NULL
5°	NULL
10°	NULL
20°	NULL
40°	NULL
th	NULL
2h	NULL
witn	NULL
a	NULL
<	NULL
-	NULL
IB	NULL
-	NULL
»	NULL
cima	NULL
«	NULL
wore	NULL
.	NULL

PMA	NULL
+	NULL
IONOMYCIN	NULL
TNF	NULL
0	NULL
5°	NULL
10°	NULL
20°	NULL
0	NULL
25°	NULL
5	NULL
10°	NULL
20°	NULL
-	NULL
<	NULL
-	NULL
p50/p65	NULL
-	NULL
»	NULL
ai	NULL
n	NULL
--	NULL
-	NULL
ps0pso	NULL
-	NULL
»	NULL
Uw	NULL
w	NULL
w	NULL
w	NULL
«	NULL
SYR	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Stimulation	NULL
of	NULL
U937	NULL
cells	NULL
caused	NULL
rapid	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
xB-a	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
followed	NULL
by	NULL
resynthesis	NULL
of	NULL
IxB-a	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
of	NULL
IxB-a	NULL
in	NULL
extracts	NULL
of	NULL
stimulated	NULL
U937	NULL
cells	NULL
(	NULL
10°	NULL
cells	NULL
per	NULL
lane	NULL
)	NULL
.	NULL

PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
or	NULL
TNF-a	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
with	NULL
and	NULL
without	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
cells	NULL
(	NULL
108	NULL
per	NULL
ml	NULL
)	NULL
for	NULL
times	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
showing	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
P-labeled	NULL
«	NULL
B	NULL
DNA	NULL
(	NULL
PD	NULL
probe	NULL
)	NULL
in	NULL
extracts	NULL
described	NULL
in	NULL
A	NULL
.	NULL

(	NULL
36	NULL
)	NULL
with	NULL
a	NULL
P-labeled	NULL
1296-bp	NULL
Xho	NULL
I-EcoRI	NULL
restriction	NULL
fragment	NULL
from	NULL
IxB-	NULL
«	NULL
/MAD-3	NULL
full-length	NULL
cDNA	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
palindromic	NULL
(	NULL
PD	NULL
)	NULL
NFkB	NULL
binding	NULL
sequence	NULL
as	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Immunofluorescent	NULL
Staining	NULL
.	NULL

NTera-2	NULL
cells	NULL
were	NULL
seeded	NULL
on	NULL
glass	NULL
coverslips	NULL
,	NULL
transfected	NULL
,	NULL
and	NULL
,	NULL
36	NULL
h	NULL
later	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
fixed	NULL
for	NULL
10	NULL
min	NULL
in	NULL
acetone/methanol	NULL
(	NULL
1:1	NULL
)	NULL
.	NULL

To	NULL
stain	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
blocking	NULL
solution	NULL
containing	NULL
PBS	NULL
plus	NULL
5	NULL
%	NULL
preimmune	NULL
goat	NULL
serum	NULL
.	NULL

Blocking	NULL
solution	NULL
was	NULL
removed	NULL
and	NULL
replaced	NULL
with	NULL
a	NULL
1:50	NULL
dilution	NULL
of	NULL
anti-IxB-a	NULL
or	NULL
anti-p65	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
in	NULL
PBS	NULL
plus	NULL
5	NULL
%	NULL
goat	NULL
serum	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
(	NULL
5	NULL
min	NULL
each	NULL
)	NULL
A	NULL
PMA	NULL
+	NULL
PHA	NULL
0	NULL
15°	NULL
30°	NULL
th	NULL
2h	NULL
4h	NULL
8h	NULL
0	NULL
25°	NULL
5°	NULL
10°	NULL
20°	NULL
40	NULL
'	NULL
th	NULL
2h	NULL
10°	NULL
2h	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
2533	NULL
fluorescein-labeled	NULL
goat	NULL
anti-rabbit	NULL
antibody	NULL
(	NULL
Tago	NULL
)	NULL
diluted	NULL
1:50	NULL
in	NULL
PBS	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Slides	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
in	NULL
PBS	NULL
,	NULL
air	NULL
dried	NULL
,	NULL
and	NULL
viewed	NULL
under	NULL
UV	NULL
fluorescence	NULL
(	NULL
Zeiss	NULL
Axioplan	NULL
)	NULL
with	NULL
oil	NULL
immersion	NULL
.	NULL

RESULTS	NULL
Stimulation	NULL
by	NULL
PMA	NULL
or	NULL
TNF-a	NULL
Causes	NULL
Rapid	NULL
,	NULL
Transient	NULL
Loss	NULL
of	NULL
IxB-a	NULL
«	NULL
.	NULL

Stimulation	NULL
of	NULL
U937	NULL
monocytic	NULL
cells	NULL
or	NULL
Jurkat	NULL
T	NULL
cells	NULL
led	NULL
to	NULL
rapid	NULL
disappearance	NULL
of	NULL
IxB-a	NULL
as	NULL
judged	NULL
by	NULL
Western	NULL
blots	NULL
of	NULL
cell	NULL
extracts	NULL
(	NULL
Figs	NULL
.	NULL

14	NULL
and	NULL
24	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

14	NULL
shows	NULL
the	NULL
time	NULL
course	NULL
of	NULL
IxB-a	NULL
degradation	NULL
in	NULL
U937	NULL
cells	NULL
following	NULL
activation	NULL
by	NULL
PMA	NULL
plus	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
or	NULL
by	NULL
TNF-a	NULL
.	NULL

Disappearance	NULL
of	NULL
IxB-a	NULL
was	NULL
rapid	NULL
but	NULL
transient	NULL
.	NULL

Undetectable	NULL
10	NULL
min	NULL
after	NULL
stimulation	NULL
,	NULL
IkB-a	NULL
reappeared	NULL
between	NULL
20	NULL
and	NULL
40	NULL
min	NULL
,	NULL
reaching	NULL
levels	NULL
equal	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

The	NULL
reappearance	NULL
of	NULL
IxB-a	NULL
was	NULL
inhibited	NULL
by	NULL
cycloheximide	NULL
,	NULL
demonstrating	NULL
a	NULL
requirement	NULL
for	NULL
protein	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
right	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
PMA	NULL
alone	NULL
gave	NULL
similar	NULL
results	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
stimulated	NULL
by	NULL
PMA	NULL
plus	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
or	NULL
by	NULL
'TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
showed	NULL
modulation	NULL
of	NULL
I	NULL
«	NULL
B-a	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
for	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
different	NULL
IxB-a	NULL
antibodies	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
disappearance	NULL
of	NULL
IxB-a	NULL
upon	NULL
stimulation	NULL
was	NULL
not	NULL
due	NULL
to	NULL
shielding	NULL
of	NULL
a	NULL
particular	NULL
epitope	NULL
caused	NULL
by	NULL
modification	NULL
of	NULL
the	NULL
IxB-a	NULL
protein	NULL
.	NULL

A	NULL
new	NULL
,	NULL
transient	NULL
,	NULL
activation-dependent	NULL
species	NULL
of	NULL
IxB-a	NULL
«	NULL
was	NULL
detected	NULL
in	NULL
U937	NULL
cells	NULL
soon	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
when	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phos-phatase	NULL
inhibitors	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
new	NULL
species	NULL
migrated	NULL
slightly	NULL
slower	NULL
than	NULL
the	NULL
IxB-	NULL
«	NULL
of	NULL
unstimulated	NULL
cells	NULL
and	NULL
rapidly	NULL
disappeared	NULL
with	NULL
further	NULL
stimulation	NULL
.	NULL

It	NULL
is	NULL
presumably	NULL
a	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxB-a	NULL
;	NULL
however	NULL
,	NULL
this	NULL
remains	NULL
to	NULL
be	NULL
demonstrated	NULL
directly	NULL
.	NULL

The	NULL
modified	NULL
form	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
PMA-stimulated	NULL
U937	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Degradation	NULL
of	NULL
IxB-a	NULL
Is	NULL
Correlated	NULL
with	NULL
NF-xB	NULL
Activation	NULL
.	NULL

The	NULL
disappearance	NULL
of	NULL
IxB-a	NULL
from	NULL
the	NULL
cell	NULL
following	NULL
stimulation	NULL
correlated	NULL
closely	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
U937	NULL
TNF	NULL
+	NULL
CHX	NULL
fr	NULL
sg	NULL
15	NULL
30°	NULL
1h	NULL
2h	NULL
8h	NULL
15°	NULL
30	NULL
'	NULL
th	NULL
2h	NULL
8h	NULL
thls	NULL
:	NULL
mame	NULL
--	NULL
owen	NULL
-a-	NULL
1B	NULL
-	NULL
»	NULL
Allt	NULL
r	NULL
PMA	NULL
+	NULL
PHA	NULL
TNF	NULL
TNF	NULL
0	NULL
15	NULL
30°	NULL
th	NULL
2h	NULL
0	NULL
15°	NULL
30°	NULL
th	NULL
2h	NULL
0	NULL
15¢	NULL
120'15'+	NULL
(	NULL
105'-TNF	NULL
)	NULL
j	NULL
g	NULL
'	NULL
-ap50/p65	NULL
»	NULL
i	NULL
,	NULL
|	NULL
&	NULL
.	NULL

de	NULL
-a	NULL
p50/p65	NULL
-a	NULL
p50/p50	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Stimulation	NULL
of	NULL
Jurkat	NULL
cells	NULL
caused	NULL
rapid	NULL
degradation	NULL
of	NULL
IxB-a	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
followed	NULL
by	NULL
resynthesis	NULL
of	NULL
IxB-a	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
of	NULL
IxB-a	NULL
in	NULL
extracts	NULL
of	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
experimental	NULL
procedure	NULL
was	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
except	NULL
that	NULL
in	NULL
the	NULL
left	NULL
panel	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
40	NULL
ng/ml	NULL
)	NULL
plus	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
showing	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
``	NULL
P-labeled	NULL
«	NULL
B	NULL
DNA	NULL
(	NULL
PD	NULL
probe	NULL
)	NULL
in	NULL
extracts	NULL
described	NULL
in	NULL
A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
showing	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
P-labeled	NULL
«	NULL
B	NULL
DNA	NULL
(	NULL
PD	NULL
probe	NULL
)	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
for	NULL
times	NULL
shown	NULL
.	NULL

The	NULL
far	NULL
right	NULL
lane	NULL
shows	NULL
binding	NULL
in	NULL
nuclear	NULL
extract	NULL
of	NULL
cells	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
after	NULL
which	NULL
cells	NULL
were	NULL
centrifuged	NULL
,	NULL
washed	NULL
with	NULL
warm	NULL
medium	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
105	NULL
min	NULL
in	NULL
fresh	NULL
medium	NULL
with	NULL
two	NULL
TNF-a	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
0.5	NULL
ug/ml	NULL
each	NULL
)	NULL
(	NULL
UBI	NULL
,	NULL
Olympus	NULL
,	NULL
Lake	NULL
Success	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

2534	NULL
Immunology	NULL
:	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

TNF	NULL
0	NULL
2	NULL
'	NULL
5'°	NULL
10	NULL
IkB	NULL
--	NULL
t	NULL
»	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Stimulated	NULL
U937	NULL
cells	NULL
produced	NULL
a	NULL
modified	NULL
,	NULL
short-lived	NULL
form	NULL
of	NULL
IxB-a	NULL
«	NULL
.	NULL

Western	NULL
blot	NULL
of	NULL
IkB-a	NULL
in	NULL
cell	NULL
extracts	NULL
of	NULL
U937	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
for	NULL
the	NULL
times	NULL
shown	NULL
.	NULL

The	NULL
modified	NULL
form	NULL
of	NULL
IkB-a	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
dot	NULL
.	NULL

The	NULL
experimental	NULL
procedure	NULL
was	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
except	NULL
that	NULL
following	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
containing	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
and	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
lysis	NULL
on	NULL
ice	NULL
in	NULL
Tris	NULL
HCl	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
containing	NULL
NaCl	NULL
(	NULL
100	NULL
mM	NULL
)	NULL
,	NULL
sodium	NULL
pyrophosphate	NULL
(	NULL
30	NULL
mM	NULL
)	NULL
,	NULL
NaF	NULL
(	NULL
50	NULL
mM	NULL
)	NULL
,	NULL
sodium	NULL
orthovanadate	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
0.5	NULL
mM	NULL
)	NULL
,	NULL
leupeptin	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
aprotinin	NULL
(	NULL
10	NULL
ug/m1	NULL
)	NULL
.	NULL

cells	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
p50/p65	NULL
)	NULL
was	NULL
easily	NULL
detected	NULL
2.5-5	NULL
min	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
binding	NULL
activity	NULL
was	NULL
composed	NULL
largely	NULL
of	NULL
p50/	NULL
p65	NULL
heterodimers	NULL
as	NULL
determined	NULL
by	NULL
supershifting	NULL
with	NULL
specific	NULL
antibodies	NULL
.	NULL

These	NULL
experiments	NULL
also	NULL
confirmed	NULL
that	NULL
the	NULL
faster	NULL
migrating	NULL
species	NULL
present	NULL
in	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
was	NULL
composed	NULL
of	NULL
p50	NULL
homodimers	NULL
[	NULL
not	NULL
shown	NULL
;	NULL
the	NULL
band	NULL
assignments	NULL
concur	NULL
with	NULL
earlier	NULL
reports	NULL
(	NULL
22	NULL
,	NULL
37-39	NULL
)	NULL
]	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
continued	NULL
to	NULL
increase	NULL
in	NULL
concert	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
IxB-a	NULL
for	NULL
up	NULL
to	NULL
10	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
or	NULL
with	NULL
TNF-a	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
of	NULL
resting	NULL
and	NULL
stimulated	NULL
Jurkat	NULL
and	NULL
U937	NULL
cells	NULL
revealed	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
I	NULL
«	NULL
xB-a	NULL
correlated	NULL
with	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
the	NULL
cytoplasm	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
shows	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
;	NULL
U937	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Provided	NULL
that	NULL
the	NULL
external	NULL
stimulus	NULL
was	NULL
maintained	NULL
,	NULL
nuclear	NULL
pS0/p65	NULL
levels	NULL
remained	NULL
high	NULL
despite	NULL
the	NULL
appearance	NULL
of	NULL
newly	NULL
synthesized	NULL
I	NULL
«	NULL
B-a	NULL
(	NULL
a	NULL
2-h	NULL
stimulation	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
NF-	NULL
«	NULL
B	NULL
persists	NULL
in	NULL
the	NULL
nucleus	NULL
with	NULL
continued	NULL
stimulation	NULL
is	NULL
unclear	NULL
.	NULL

When	NULL
TNF-a	NULL
was	NULL
removed	NULL
after	NULL
15	NULL
min	NULL
by	NULL
washing	NULL
and	NULL
addition	NULL
of	NULL
TNF-a	NULL
antibodies	NULL
,	NULL
nuclear	NULL
p50/p65	NULL
binding	NULL
activity	NULL
declined	NULL
rapidly	NULL
,	NULL
in	NULL
accord	NULL
with	NULL
a	NULL
prior	NULL
report	NULL
(	NULL
40	NULL
)	NULL
(	NULL
a	NULL
105-min	NULL
time	NULL
point	NULL
following	NULL
removal	NULL
of	NULL
TNF-a	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
brief	NULL
stimulation	NULL
by	NULL
TNF-a	NULL
produced	NULL
a	NULL
transient	NULL
loss	NULL
of	NULL
IxB-a	NULL
and	NULL
only	NULL
a	NULL
transient	NULL
increase	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
(	NULL
p50/p65	NULL
)	NULL
.	NULL

Kinetics	NULL
of	NULL
IxB-a	NULL
mRNA	NULL
Induction	NULL
Following	NULL
Stimulation	NULL
.	NULL

Stimulation	NULL
of	NULL
U937	NULL
by	NULL
PMA	NULL
or	NULL
TNF-a	NULL
for	NULL
short	NULL
periods	NULL
,	NULL
up	NULL
to	NULL
10	NULL
min	NULL
,	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
level	NULL
of	NULL
IxB-a	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

By	NULL
this	NULL
time	NULL
IxB-a	NULL
protein	NULL
had	NULL
disappeared	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
PMA	NULL
TNF	NULL
[	NULL
J	NULL
1	NULL
0	NULL
5°	NULL
10°	NULL
20	NULL
'	NULL
40°	NULL
0	NULL
5°	NULL
10°	NULL
20°	NULL
40°	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Stimulation	NULL
of	NULL
U937	NULL
cells	NULL
caused	NULL
induction	NULL
of	NULL
IxB-a	NULL
mRNA	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
IxB-a	NULL
RNA	NULL
extracted	NULL
from	NULL
U937	NULL
cells	NULL
(	NULL
10°	NULL
per	NULL
ml	NULL
)	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
TNF-a	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
for	NULL
times	NULL
shown	NULL
.	NULL

Each	NULL
lane	NULL
contained	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
the	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
*°P-labeled	NULL
IxB-a	NULL
cDNA	NULL
.	NULL

As	NULL
a	NULL
control	NULL
the	NULL
blot	NULL
shown	NULL
was	NULL
reprobed	NULL
with	NULL
glyceraldehyde-3-phosphate	NULL
dehydroge-nase	NULL
(	NULL
GAPDH	NULL
)	NULL
cDNA	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

No	NULL
change	NULL
in	NULL
the	NULL
level	NULL
of	NULL
GAPDH	NULL
mRNA	NULL
with	NULL
stimulation	NULL
was	NULL
seen	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
was	NULL
activated	NULL
.	NULL

IxB-a	NULL
mRNA	NULL
levels	NULL
surged	NULL
,	NULL
however	NULL
,	NULL
by	NULL
20	NULL
min	NULL
.	NULL

Again	NULL
,	NULL
Jurkat	NULL
cells	NULL
behaved	NULL
similarly	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
the	NULL
loss	NULL
of	NULL
IkB-a	NULL
that	NULL
follows	NULL
quickly	NULL
after	NULL
stimulation	NULL
was	NULL
not	NULL
associated	NULL
with	NULL
a	NULL
loss	NULL
of	NULL
mRNA	NULL
,	NULL
the	NULL
new	NULL
IkB-a	NULL
protein	NULL
synthesis	NULL
observed	NULL
subsequently	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
massive	NULL
increase	NULL
in	NULL
IxB-	NULL
«	NULL
mRNA	NULL
,	NULL
which	NULL
accords	NULL
with	NULL
the	NULL
cycloheximide	NULL
sensitivity	NULL
of	NULL
this	NULL
IxB-a	NULL
protein	NULL
induction	NULL
.	NULL

Induction	NULL
of	NULL
IxB-a	NULL
by	NULL
p65	NULL
and	NULL
c-Rel	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
IxB-a	NULL
mRNA	NULL
and	NULL
protein	NULL
shortly	NULL
after	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
suggested	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
directly	NULL
responsible	NULL
.	NULL

Undifferentiated	NULL
NTera-2	NULL
human	NULL
embryonic	NULL
carcinoma	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
various	NULL
plasmid	NULL
constructs	NULL
directing	NULL
the	NULL
synthesis	NULL
of	NULL
components	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
devoid	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
(	NULL
9	NULL
)	NULL
and	NULL
contained	NULL
no	NULL
detectable	NULL
IxB-a	NULL
protein	NULL
or	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
NTera-2	NULL
cells	NULL
with	NULL
p65	NULL
,	NULL
known	NULL
to	NULL
form	NULL
potently	NULL
transactivating	NULL
homodimers	NULL
(	NULL
7	NULL
,	NULL
13	NULL
,	NULL
41	NULL
)	NULL
,	NULL
generated	NULL
high	NULL
levels	NULL
of	NULL
endogenous	NULL
IxB-a	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
and	NULL
A	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
simplest	NULL
explanation	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
IxB-a	NULL
mRNA	NULL
is	NULL
direct	NULL
transactivation	NULL
of	NULL
this	NULL
gene	NULL
,	NULL
A	NULL
B	NULL
uo	NULL
x	NULL
<	NULL
&	NULL
9	NULL
am	NULL
[	NULL
cel	NULL
8B	NULL
as	NULL
gg	NULL
f	NULL
¢	NULL
C	NULL
IkB	NULL
Ab	NULL
IkB	NULL
Ab	NULL
vector	NULL
alone	NULL
p65	NULL
IkB	NULL
Ab	NULL
p65	NULL
Ab	NULL
p50/p65	NULL
p65	NULL
Fig	NULL
.	NULL

5.	NULL
p65	NULL
,	NULL
p50/p65	NULL
,	NULL
and	NULL
c-Rel	NULL
induced	NULL
IxB-a	NULL
in	NULL
transfected	NULL
NTera-2	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Western	NULL
blot	NULL
of	NULL
IxB-a	NULL
protein	NULL
produced	NULL
in	NULL
cell	NULL
extracts	NULL
of	NULL
NTera-2	NULL
transiently	NULL
transfected	NULL
with	NULL
PMT2T	NULL
(	NULL
vector	NULL
)	NULL
bearing	NULL
cDNAs	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
Western	NULL
blotting	NULL
procedure	NULL
was	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
in	NULL
100-mm	NULL
Petri	NULL
dishes	NULL
were	NULL
transfected	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
and	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Each	NULL
lane	NULL
was	NULL
loaded	NULL
with	NULL
the	NULL
extract	NULL
of	NULL
1.5	NULL
x	NULL
108	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
of	NULL
IxB-a	NULL
mRNA	NULL
produced	NULL
in	NULL
NTera-2	NULL
cells	NULL
transfected	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
PMT2T	NULL
(	NULL
vector	NULL
)	NULL
or	NULL
PMT2T-p65	NULL
.	NULL

Each	NULL
lane	NULL
was	NULL
loaded	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
the	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
+P-labeled	NULL
IxB-a	NULL
cDNA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunofluorescent	NULL
stained	NULL
transfected	NULL
NTera-2	NULL
cells	NULL
.	NULL

The	NULL
upper	NULL
left	NULL
panel	NULL
shows	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
PMT2T	NULL
vector	NULL
plasmid	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
stained	NULL
for	NULL
IxB-a	NULL
.	NULL

The	NULL
upper	NULL
right	NULL
and	NULL
lower	NULL
left	NULL
panels	NULL
show	NULL
cells	NULL
transfected	NULL
with	NULL
p65	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
and	NULL
p65	NULL
plus	NULL
pSO	NULL
(	NULL
2	NULL
ug	NULL
each	NULL
)	NULL
cDNAs	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
IkB-a	NULL
.	NULL

The	NULL
lower	NULL
right	NULL
panel	NULL
shows	NULL
cells	NULL
transfected	NULL
with	NULL
p65	NULL
stained	NULL
for	NULL
p65	NULL
.	NULL

Ab	NULL
,	NULL
antibody	NULL
.	NULL

Immunology	NULL
:	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

presumably	NULL
through	NULL
a	NULL
«	NULL
B	NULL
element	NULL
.	NULL

It	NULL
is	NULL
formally	NULL
possible	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
increase	NULL
is	NULL
mediated	NULL
indirectly	NULL
or	NULL
is	NULL
due	NULL
to	NULL
mRNA	NULL
stabilization	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
p65	NULL
,	NULL
transfection	NULL
with	NULL
p50	NULL
,	NULL
which	NULL
generates	NULL
non-transactivating	NULL
p50	NULL
homodimers	NULL
(	NULL
7	NULL
,	NULL
9	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
41	NULL
)	NULL
,	NULL
did	NULL
not	NULL
induce	NULL
IxB-a	NULL
synthesis	NULL
.	NULL

It	NULL
is	NULL
curious	NULL
that	NULL
transfection	NULL
with	NULL
the	NULL
IxB-a	NULL
expression	NULL
construct	NULL
did	NULL
not	NULL
result	NULL
in	NULL
detectable	NULL
levels	NULL
of	NULL
the	NULL
encoded	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
high	NULL
,	NULL
functional	NULL
levels	NULL
of	NULL
IxB-a	NULL
can	NULL
be	NULL
expressed	NULL
from	NULL
this	NULL
plasmid	NULL
when	NULL
cotransfected	NULL
with	NULL
potential	NULL
targets	NULL
for	NULL
inhibition	NULL
and	NULL
binding	NULL
,	NULL
such	NULL
as	NULL
p65	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Binding	NULL
to	NULL
target	NULL
proteins	NULL
may	NULL
therefore	NULL
stabilize	NULL
IxB-	NULL
«	NULL
,	NULL
allowing	NULL
its	NULL
detection	NULL
in	NULL
Western	NULL
blots	NULL
.	NULL

We	NULL
speculate	NULL
further	NULL
that	NULL
the	NULL
inherent	NULL
instability	NULL
of	NULL
free	NULL
IxB-a	NULL
is	NULL
the	NULL
basis	NULL
for	NULL
its	NULL
rapid	NULL
removal	NULL
from	NULL
the	NULL
cell	NULL
upon	NULL
activation-induced	NULL
dissociation	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
the	NULL
transfection	NULL
of	NULL
pSO	NULL
plus	NULL
p65	NULL
and	NULL
of	NULL
c-Rel	NULL
also	NULL
induced	NULL
considerable	NULL
levels	NULL
of	NULL
IxB-a	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
the	NULL
respective	NULL
dimers	NULL
being	NULL
capable	NULL
of	NULL
transactivation	NULL
and	NULL
being	NULL
targets	NULL
for	NULL
binding	NULL
and	NULL
inhibition	NULL
by	NULL
IxB-a	NULL
(	NULL
11	NULL
,	NULL
20-24	NULL
,	NULL
31	NULL
,	NULL
42-45	NULL
)	NULL
.	NULL

Immunofluorescent	NULL
staining	NULL
of	NULL
IxB-a	NULL
confirmed	NULL
the	NULL
induction	NULL
and	NULL
cytoplasmic	NULL
location	NULL
of	NULL
this	NULL
protein	NULL
in	NULL
NTera-2	NULL
cells	NULL
transfected	NULL
with	NULL
p65	NULL
or	NULL
with	NULL
p50/p65	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Staining	NULL
for	NULL
p65	NULL
revealed	NULL
high	NULL
levels	NULL
of	NULL
this	NULL
protein	NULL
in	NULL
p65	NULL
transfected	NULL
cells	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
p6S	NULL
in	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
compartments	NULL
suggested	NULL
that	NULL
the	NULL
highly	NULL
abundant	NULL
exoge-nously	NULL
introduced	NULL
p65	NULL
is	NULL
partially	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
the	NULL
induced	NULL
endogenous	NULL
IkB-a	NULL
.	NULL

DISCUSSION	NULL
We	NULL
show	NULL
here	NULL
that	NULL
IxB-a	NULL
is	NULL
physiologically	NULL
regulated	NULL
by	NULL
rapid	NULL
removal	NULL
from	NULL
the	NULL
cell	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
.	NULL

In	NULL
three	NULL
cell	NULL
types	NULL
tested-the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
Jurkat	NULL
T	NULL
lym-phocytes	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
cells-IxB-a	NULL
was	NULL
present	NULL
in	NULL
unstimulated	NULL
cells	NULL
but	NULL
disappeared	NULL
within	NULL
a	NULL
few	NULL
minutes	NULL
of	NULL
stimulation	NULL
by	NULL
PMA	NULL
or	NULL
TNF-a	NULL
.	NULL

The	NULL
removal	NULL
of	NULL
IkB-a	NULL
is	NULL
coupled	NULL
to	NULL
a	NULL
concomitant	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
predom-inantly	NULL
p50/p65	NULL
)	NULL
from	NULL
the	NULL
cytoplasm	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

How	NULL
does	NULL
activation	NULL
increase	NULL
the	NULL
lability	NULL
of	NULL
IxB-a	NULL
protein	NULL
?	NULL

There	NULL
are	NULL
at	NULL
least	NULL
two	NULL
possible	NULL
explanations	NULL
:	NULL
(	NULL
i	NULL
)	NULL
modification	NULL
of	NULL
IkB-a	NULL
and/or	NULL
its	NULL
bound	NULL
partners	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
p50/p65	NULL
)	NULL
,	NULL
rendering	NULL
it	NULL
susceptible	NULL
to	NULL
hydrolysis	NULL
by	NULL
a	NULL
cytoplasmic	NULL
protease	NULL
;	NULL
this	NULL
increased	NULL
susceptibility	NULL
could	NULL
result	NULL
simply	NULL
from	NULL
the	NULL
release	NULL
of	NULL
the	NULL
modified	NULL
IkB-a	NULL
as	NULL
a	NULL
free	NULL
,	NULL
labile	NULL
molecule	NULL
;	NULL
(	NULL
i	NULL
?	NULL
)	NULL

activation	NULL
of	NULL
a	NULL
cytoplasmic	NULL
protease	NULL
with	NULL
specificity	NULL
for	NULL
IxB-a	NULL
@	NULL
.	NULL

Though	NULL
not	NULL
excluding	NULL
the	NULL
latter	NULL
explanation	NULL
,	NULL
our	NULL
data	NULL
support	NULL
the	NULL
former	NULL
.	NULL

The	NULL
observation	NULL
of	NULL
a	NULL
short-lived	NULL
,	NULL
more	NULL
slowly	NULL
migrating	NULL
species	NULL
of	NULL
IxB-a	NULL
in	NULL
stimulated	NULL
U937	NULL
cells	NULL
suggests	NULL
that	NULL
modification	NULL
of	NULL
IxB-a	NULL
«	NULL
occurs	NULL
and	NULL
may	NULL
precede	NULL
dissociation	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
degradation	NULL
.	NULL

Secondly	NULL
,	NULL
because	NULL
no	NULL
I	NULL
«	NULL
B-a	NULL
«	NULL
protein	NULL
could	NULL
be	NULL
demonstrated	NULL
even	NULL
upon	NULL
transfection	NULL
with	NULL
IkB-a	NULL
expression	NULL
vectors	NULL
in	NULL
NTera-2	NULL
cells	NULL
that	NULL
lack	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
IkB-a	NULL
appears	NULL
to	NULL
be	NULL
inherently	NULL
unstable	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
partners	NULL
.	NULL

IxB-a	NULL
is	NULL
stabilized	NULL
and	NULL
readily	NULL
detected	NULL
in	NULL
NTera-2	NULL
cells	NULL
transfected	NULL
with	NULL
p65	NULL
,	NULL
p50/p65	NULL
,	NULL
or	NULL
c-Rel	NULL
.	NULL

Our	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
activation-induced	NULL
modification	NULL
of	NULL
IxB-a	NULL
and/or	NULL
its	NULL
bound	NULL
NF-	NULL
«	NULL
B	NULL
partner	NULL
leads	NULL
to	NULL
dissociation	NULL
of	NULL
IxB-a	NULL
«	NULL
,	NULL
rendering	NULL
it	NULL
susceptible	NULL
to	NULL
immediate	NULL
protease	NULL
attack	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
IkB-a	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
upon	NULL
stimulation	NULL
are	NULL
transient	NULL
phenomena	NULL
.	NULL

IxB-	NULL
«	NULL
mRNA	NULL
transcription	NULL
is	NULL
quickly	NULL
induced	NULL
,	NULL
leading	NULL
to	NULL
replenishment	NULL
of	NULL
the	NULL
IkB-a	NULL
protein	NULL
level	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
endogenous	NULL
IxB-a	NULL
«	NULL
mRNA	NULL
upon	NULL
transfection	NULL
of	NULL
NTera-2	NULL
cells	NULL
with	NULL
transactiva-tors	NULL
such	NULL
as	NULL
p65	NULL
suggests	NULL
direct	NULL
transactivation	NULL
of	NULL
the	NULL
IxB-a	NULL
gene	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
possibly	NULL
through	NULL
a	NULL
«	NULL
B	NULL
element	NULL
.	NULL

Thus	NULL
,	NULL
p65	NULL
positively	NULL
regulates	NULL
IxB-a	NULL
,	NULL
probably	NULL
by	NULL
transcriptional	NULL
acti-vation	NULL
,	NULL
and	NULL
may	NULL
also	NULL
regulate	NULL
IkB-a	NULL
turnover	NULL
by	NULL
post-translational	NULL
stabilization	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
p65	NULL
homodimers	NULL
,	NULL
p50/p65	NULL
and	NULL
c-Rel	NULL
have	NULL
similar	NULL
effects	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
2535	NULL
Cellular	NULL
Activation	NULL
Signal	NULL
|	NULL
Y	NULL
Replenishment	NULL
Modification-Degradation	NULL
IkB-a	NULL
--	NULL
-3~-	NULL
#	NULL
»	NULL
NF-	NULL
«	NULL
B	NULL
-	NULL
IxB-x	NULL
Ix	NULL
*	NULL
l/	NULL
Cytoplasm	NULL
Nucleus	NULL
\	NULL
x	NULL
~	NULL
~	NULL
Activated	NULL
NF-xB	NULL
IxB-o	NULL
mRNA	NULL
<	NULL
——/	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Model	NULL
depicting	NULL
the	NULL
mutual	NULL
regulation	NULL
of	NULL
IxB-a	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Activation-induced	NULL
IxB-a	NULL
degradation	NULL
is	NULL
coupled	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
leads	NULL
to	NULL
new	NULL
IxB-a	NULL
synthesis	NULL
.	NULL

The	NULL
broken	NULL
line	NULL
indicates	NULL
possible	NULL
recycling	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
see	NULL
text	NULL
)	NULL
.	NULL

IkB-a	NULL
,	NULL
as	NULL
may	NULL
other	NULL
Rel-related	NULL
,	NULL
transactivating	NULL
combinations	NULL
that	NULL
can	NULL
associate	NULL
with	NULL
IxB-a	NULL
.	NULL

Our	NULL
working	NULL
model	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Stimulation	NULL
triggers	NULL
signal	NULL
transduction	NULL
,	NULL
which	NULL
may	NULL
lead	NULL
to	NULL
modification	NULL
of	NULL
IxB-a	NULL
,	NULL
probably	NULL
by	NULL
phosphorylation	NULL
,	NULL
and	NULL
dissociation	NULL
from	NULL
cytoplasmic	NULL
NF-kB	NULL
.	NULL

Components	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
factor	NULL
may	NULL
also	NULL
undergo	NULL
modification	NULL
assisting	NULL
the	NULL
release	NULL
of	NULL
IxB-a	NULL
.	NULL

The	NULL
resulting	NULL
free	NULL
,	NULL
modified	NULL
IxB-a	NULL
is	NULL
rapidly	NULL
degraded	NULL
by	NULL
a	NULL
protease	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
causing	NULL
a	NULL
pulse	NULL
of	NULL
«	NULL
B-dependent	NULL
transcription	NULL
that	NULL
is	NULL
prolonged	NULL
only	NULL
if	NULL
external	NULL
stimulation	NULL
continues	NULL
.	NULL

IxB-a	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
genes	NULL
targeted	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
surge	NULL
of	NULL
IxB-a	NULL
mRNA	NULL
synthesis	NULL
,	NULL
restoring	NULL
its	NULL
protein	NULL
levels	NULL
in	NULL
the	NULL
cell	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
further	NULL
stimulation	NULL
,	NULL
the	NULL
newly	NULL
formed	NULL
IxB-a	NULL
may	NULL
assist	NULL
in	NULL
removing	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
since	NULL
no	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
remains	NULL
soon	NULL
after	NULL
elimination	NULL
of	NULL
the	NULL
signal	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

This	NULL
action	NULL
of	NULL
IxB-a	NULL
could	NULL
be	NULL
the	NULL
physiological	NULL
role	NULL
for	NULL
the	NULL
inhibitor	NULL
's	NULL
ability	NULL
to	NULL
remove	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

Newly	NULL
formed	NULL
IxB-	NULL
«	NULL
may	NULL
also	NULL
sequester	NULL
de	NULL
novo	NULL
synthesized	NULL
NF-KB	NULL
factors	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

Activation-induced	NULL
synthesis	NULL
of	NULL
components	NULL
of	NULL
NF-KB	NULL
factors	NULL
does	NULL
not	NULL
commence	NULL
until	NULL
well	NULL
after	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
(	NULL
5	NULL
,	NULL
9	NULL
,	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
mutual	NULL
regulation	NULL
of	NULL
IxB-a	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
ensures	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
environmental	NULL
stimuli	NULL
is	NULL
limited-	NULL
-and	NULL
transient	NULL
.	NULL

Activation	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
subject	NULL
to	NULL
a	NULL
negative	NULL
feedback	NULL
regulation	NULL
through	NULL
strong	NULL
induction	NULL
of	NULL
IkB-a	NULL
synthesis	NULL
.	NULL

IxB-a	NULL
production	NULL
is	NULL
geared	NULL
to	NULL
saturate	NULL
its	NULL
free	NULL
NF-	NULL
«	NULL
B	NULL
partners	NULL
,	NULL
acting	NULL
to	NULL
restore	NULL
an	NULL
equilibrium	NULL
of	NULL
inhibition	NULL
following	NULL
stimulation	NULL
.	NULL

Any	NULL
excess	NULL
of	NULL
free	NULL
IxB-a	NULL
is	NULL
quickly	NULL
degraded	NULL
.	NULL

NF-KB	NULL
and	NULL
IxB-a	NULL
are	NULL
thus	NULL
locked	NULL
in	NULL
a	NULL
tightly	NULL
controlled	NULL
circuit	NULL
of	NULL
mutual	NULL
regulation	NULL
.	NULL

We	NULL
thank	NULL
A.	NULL
S.	NULL
Fauci	NULL
for	NULL
his	NULL
continued	NULL
support	NULL
,	NULL
encouragement	NULL
,	NULL
and	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
K.	NULL
Kelly	NULL
and	NULL
V.	NULL
Bours	NULL
for	NULL
their	NULL
helpful	NULL
discussion	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
thank	NULL
D.	NULL
Levens	NULL
and	NULL
S.	NULL
Mackem	NULL
for	NULL
their	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
C.	NULL
Rosen	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
and	NULL
N.	NULL
Rice	NULL
for	NULL
the	NULL
p65	NULL
,	NULL
IxB-a/MAD-3	NULL
,	NULL
and	NULL
c-Rel	NULL
cDNA	NULL
clones	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
thank	NULL
V.	NULL
Azarenko	NULL
for	NULL
her	NULL
skilled	NULL
technical	NULL
assistance	NULL
and	NULL
M.	NULL
Rust	NULL
,	NULL
M.	NULL
Le	NULL
,	NULL
and	NULL
G.	NULL
Wood	NULL
for	NULL
help	NULL
in	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

1	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072	NULL
,	NULL
63-80	NULL
.	NULL

2	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.	NULL
J.-S.	NULL
&	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

148	NULL
,	NULL
1-63	NULL
.	NULL

3	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerchkhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kouriisky	NULL
,	NULL
P.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

_	NULL
4	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

5	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
&	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
348	NULL
,	NULL
76-80	NULL
.	NULL

6	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Hohmann	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Haiker	NULL
,	NULL
M.	NULL
,	NULL
Bartsch	NULL
,	NULL
C.	NULL
,	NULL
Rothlisberger	NULL
,	NULL
U.	NULL
,	NULL
Lahm	NULL
,	NULL
H.-W.	NULL
,	NULL
Schlaeger	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
2536	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

Immunology	NULL
:	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

Van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
&	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
966-970	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Andrews	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
352	NULL
,	NULL
733-736	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
Chang	NULL
,	NULL
C.-C.	NULL
,	NULL
Lombardi	NULL
,	NULL
L.	NULL
,	NULL
Salina	NULL
,	NULL
M.	NULL
,	NULL
Corradini	NULL
,	NULL
P.	NULL
,	NULL
Maiolo	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
1075-1087	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Burd	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
&	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
685-695	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
Didonato	NULL
,	NULL
J.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

11	NULL
,	NULL
523-537	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Dillon	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
1-10	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
1875-1879	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bull	NULL
,	NULL
P.	NULL
,	NULL
Takamiya	NULL
,	NULL
M.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Dobrzanski	NULL
,	NULL
P.	NULL
&	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
674-684	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Klement	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Coleman	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
&	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
745-760	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
Mittereder	NULL
,	NULL
N.	NULL
&	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Oncogene	NULL
1	NULL
,	NULL
935-942	NULL
.	NULL

Stephens	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Hiebsch	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
&	NULL
Gilden	NULL
,	NULL
R.	NULL
V.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
,	NULL
6229-6232	NULL
.	NULL

Wilhelmsen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Eggleton	NULL
,	NULL
K.	NULL
&	NULL
Temin	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

52	NULL
,	NULL
172-182	NULL
.	NULL

Steward	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
692-694	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yu-rochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1281-1289	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1899-1913	NULL
.	NULL

Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Link	NULL
,	NULL
E.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1464-1476	NULL
.	NULL

Tewari	NULL
,	NULL
M.	NULL
,	NULL
Dobrzanski	NULL
,	NULL
P.	NULL
,	NULL
Mohn	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Cressman	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
(	NULL
1993	NULL
)	NULL
Hsu	NULL
,	NULL
J.-C.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
&	NULL
Taub	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2898-2908	NULL
.	NULL

Zabel	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
255-265	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1975-1984	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
dos	NULL
Santos	NULL
Silva	NULL
,	NULL
M.	NULL
&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
201-211	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
Bargmann	NULL
,	NULL
W.	NULL
,	NULL
Lim	NULL
,	NULL
M.-Y	NULL
.	NULL

&	NULL
Bose	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
584-591	NULL
.	NULL

Morin	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

&	NULL
Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
2453-2458	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
253	NULL
,	NULL
1268-1271	NULL
.	NULL

Link	NULL
,	NULL
E.	NULL
,	NULL
Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
239-246	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
&	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
10028-10032	NULL
.	NULL

Kaufman	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Weinberg	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
121-129	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Tomita-Yamaguchi	NULL
,	NULL
M.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
&	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
359	NULL
,	NULL
339-342	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
Remy	NULL
,	NULL
R.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C.	NULL
&	NULL
van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
259-266	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
3805-3817	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1817-1825	NULL
.	NULL

Inoue	NULL
,	NULL
J.-I	NULL
.	NULL

,	NULL
Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Rashid	NULL
,	NULL
D.	NULL
,	NULL
David	NULL
,	NULL
N.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
4333-4337	NULL
.	NULL

